Anna Marzá Florensa

152 Chapter 6 cardiovascular risk factors five years after coronary angiography. European Journal of Cardiovascular Nursing. 2018 Feb 1;17(2):136–47. 23. Jankowski P, Kawecka-Jaszcz K, Bilo G, Pajak A. Determinants of poor hypertension management in patients with ischaemic heart disease. Blood Press. 2005;14(5):284–92. 24. Peltzer S, Hellstern M, Genske A, Jünger S, Woopen C, Albus C. Health literacy in persons at risk of and patients with coronary heart disease: A systematic review. Vol. 245, Social Science and Medicine. Elsevier Ltd; 2020. 25. Sørensen K, Pelikan JM, Röthlin F, Ganahl K, Slonska Z, Doyle G, et al. Health literacy in Europe: comparative results of the European health literacy survey (HLS-EU). The European Journal of Public Health. 2015 Dec;25(6):1053–8. 26. World Health Organization, World Bank. Tracking Universal Health Coverage: 2021 Global Monitoring Report. 2021. 27. Birk MG, Carvalho Goulart A, Lotufo PA, Martins Benseñor I. Secondary prevention of coronary heart disease : a cross-sectional analysis on the Brazilian Longitudinal Study of Adult Health ( ELSA-Brasil ). Sao Paulo Med J. 2019;137(3):223–33. 28. de Carvalho Costa IMNB, Silva DG da, Oliveira JLM, Silva JRS, Pereira LMC, Alves LVS, et al. Adherence to secondary prevention measures after acute coronary syndrome in patients associated exclusively with the public and private healthcare systems in Brazil. Prev Med Rep. 2022 Oct 1;29. 29. Harrison MA, Marfo AFA, Annan A, Ankrah DNA. Access to cardiovascular medicines in low- and middle-income countries: a mini review. Vol. 8, Global Health Research and Policy. BioMed Central Ltd; 2023. 30. Yang JM, Lee S bin, Kim Y ji, Chon D young, Moon JY, Kim JH. Association between private health insurance and medical use by linking subjective health and chronic diseases. Medicine. 2022 Aug 12;101(32):e29865. 31. De Smedt D, De Backer T, Petrovic M, De Backer G, Wood D, Kotseva K, et al. Chronic medication intake in patients with stable coronary heart disease across Europe: Evidence from the daily clinical practice. Results from the ESC EORP European Survey of Cardiovascular Disease Prevention and Diabetes (EUROASPIRE IV) Registry. Int J Cardiol. 2020 Feb 1;300:7–13. 32. Kotseva K, Wood D, De Bacquer D. Determinants of participation and risk factor control according to attendance in cardiac rehabilitation programmes in coronary patients in Europe: EUROASPIRE IV survey. Eur J Prev Cardiol. 2018 Aug 1;25(12):1242–51. 33. Taylor RS, Dalal HM, McDonagh STJ. The role of cardiac rehabilitation in improving cardiovascular outcomes. Vol. 19, Nature Reviews Cardiology. Nature Research; 2022. p. 180–94. 34. Ohm J, Skoglund PH, Häbel H, Sundström J, Hambraeus K, Jernberg T, et al. Association of Socioeconomic Status with Risk Factor Target Achievements and Use of Secondary Prevention after Myocardial Infarction. JAMA Netw Open. 2021 Mar 10;4(3). 35. Sun EY, Jadotte YT, Halperin W. Disparities in cardiac rehabilitation participation in the United States: A systematic review and meta-analysis. Vol. 37, Journal of Cardiopulmonary Rehabilitation and Prevention. Lippincott Williams and Wilkins; 2017. p. 2–10. 36. Abreu A, Pesah E, Supervia M, Turk-Adawi K, Bjarnason-Wehrens B, Lopez-Jimenez F, et al. Cardiac rehabilitation availability and delivery in Europe: How does it differ by region and compare with other high-income countries?: Endorsed by the European Association of Preventive Cardiology. Eur J Prev Cardiol. 2019 Jul 1;26(11):1131–46. 37. Turk-Adawi K, Supervia M, Ghisi G, Cuenza L, Yeo TJ, Chen SY, et al. The impact of ICCPR’s Global Audit of Cardiac Rehabilitation: where are we now and where do we need to go? EClinicalMedicine. 2023 Jul;61:102092. 38. Ghisi GL de M, Taylor RS, Seron P, Grace SL. Factors Hindering Cardiac Rehabilitation in Low- and Middle-Income Countries, by Level and Setting. J Cardiopulm Rehabil Prev. 2023 Mar;43(2):143–4. 39. Gabulova R, Marzà-Florensa A, Rahimov U, Isayeva M, Alasgarli S, Musayeva A, et al. Risk factors in cardiovascular patients: Challenges and opportunities to improve secondary prevention. World J Cardiol. 2023 Jul 26;15(7):342–53. 40. World-Heart-Report-2023.

RkJQdWJsaXNoZXIy MTk4NDMw